Cargando…

Antiplatelets in Secondary Stroke Prevention

The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention. The most commonly used antiplatelets agents are aspirin, clopidogrel, and extended-release dip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shulga, Olga, Bornstein, Natan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131527/ https://www.ncbi.nlm.nih.gov/pubmed/21772826 http://dx.doi.org/10.3389/fneur.2011.00036

Ejemplares similares

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010)

Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention
por: Weber, Ralph, et al.
Publicado: (2010)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
por: O'Brien, Ellen, et al.
Publicado: (2023)

Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2015)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

A New Model for Secondary Prevention of Stroke: Transition Coaching for Stroke
por: Bushnell, Cheryl, et al.
Publicado: (2014)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: Wang, David
Publicado: (2021)

Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines
por: Shah, Jay, et al.
Publicado: (2022)

Risk of Serious Bleeding with Antiplatelet Therapy for Secondary Prevention Post Ischemic Stroke in Middle East Population
por: Awada, Zeinab, et al.
Publicado: (2019)

The Case for Diet: A Safe and Efficacious Strategy for Secondary Stroke Prevention
por: Dearborn, Jennifer L., et al.
Publicado: (2015)

Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018)

Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?
por: Balucani, Clotilde, et al.
Publicado: (2010)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis
por: Hariharan, Nikhil Nair, et al.
Publicado: (2022)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
por: Gorelick, Philip B., et al.
Publicado: (2013)

Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review
por: Signorelli, Salvatore Santo, et al.
Publicado: (2020)

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility
por: Sprigg, Nikola, et al.
Publicado: (2008)

Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Del Giovane, Cinzia, et al.
Publicado: (2021)

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
por: Hoshino, Haruhiko, et al.
Publicado: (2023)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Antiplatelets or anticoagulants? Secondary prevention in cervical artery dissection: an updated meta-analysis
por: The, Ei Zune, et al.
Publicado: (2022)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Impact of COVID-19 pandemic on acute stroke care-data analysis from the RES-Q registry 2020 in N. Macedonia
por: Arsovska, Anita, et al.
Publicado: (2021)

Diet in Stroke: Beyond Antiplatelets and Statins
por: James, Joe
Publicado: (2019)

Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice
por: Bonney, Phillip A., et al.
Publicado: (2019)

Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention
por: Wiśniewski, Adam
Publicado: (2021)

Role of prediabetes in stroke
por: Mijajlović, Milija D, et al.
Publicado: (2017)

Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
por: Weiss, Thomas W., et al.
Publicado: (2016)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

The impact of a comprehensive national policy on improving acute stroke patient care in Lithuania
por: Masiliūnas, Rytis, et al.
Publicado: (2022)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Selected acute phase CSF factors in ischemic stroke: findings and prognostic value
por: Beridze, Maia, et al.
Publicado: (2011)

Drugs in secondary stroke prevention
por: Tremonti, Chris, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tdo6ovedvj9re9dfp2ugfvd3j2